Sanofi-Aventis




Sanofi-Aventis
Public (Euronext SAN, NYSE, LSE and FWB)
FoundedAugust 20, 2004 by acquisition
HeadquartersParis, France
Key peopleJean-François Dehecq Chairman
Gérard Le Fur CEO
Industryantibiotic)
Revenue27.311 billion euros (2005)
   ($34.013 billion USD)
Employees100,000 (2007)
SloganBecause health matters. (French: L'essentiel c'est la santé.)
Websiteen.sanofi-aventis.com

Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is one of the five largest diabetes, central nervous system, internal medicine and vaccines (with its subsidiary Sanofi-Pasteur).

History

Sanofi aventis

Sanofi Aventis was formed in 2004 when Novartis, a Swiss pharmaceutical company, was in the running.

Sanofi-Synthélabo

Sanofi-Synthélabo was formed in 1999 when Sanofi (former subsidiary of Total) merged with Synthélabo (former subsidiary of L'Oréal). The merged company was based in Paris, France.

Aventis

Main article: Aventis

Aventis was formed in 1999 when Hoechst AG with Roussel Uclaf and Marion Merrell Dow. The merged company was based in Schiltigheim, near Strasbourg, France.

Business

Management

  • Jean-François Dehecq, Chairman
  • Gérard Le Fur, CEO

Dehecq has been the General Manager of Sanofi since its creation in 1973.

Stockholders

  • Breakdown of share ownership: 12.65% by Total, 10.13% by L'Oréal, 5.47% treasury shares, 1.29% employees, the remaining 70.46% are publicly traded.
  • Voting rights distribution: 21.37% to Total, 17.12% to L'Oréal, 1.54% to employees, and 59.97% to the public.

Earnings

In 2003, Sanofi-Aventis's consolidated sales was €25 bn. It has operations in more than 100 countries throughout the 5 continents and has 99,700 employees worldwide. Research and development investment was €4 bn.

  • Sales by activity breakdown: 39% from Cardiovascular/Thrombosis, 29% from Central Nervous System, 18% from Internal Medicine, 11% from Oncology, 3% from other pharmaceutical products.
  • Sales by geographic area breakdown: 58% from Europe, 24% from U.S., 18% from rest of the world.

Aventis Foundation

The Aventis Foundation, a German charitable trust, was established in 1996 as the Hoechst Foundation with an endowment of €50 million. In 2000, the foundation was renamed the Aventis Foundation subsequent to the 1999 merger of Hoechst and Rhône-Poulenc. The foundation was responsible for sponsoring the Royal Society Prizes for Science Books and are managed by the Royal Society, the UK national academy of science.

Company profiles

  • Yahoo! - Sanofi-Aventis Company Profile
v • d • e
CAC 40 companies of France

Accor · Air France-KLM · Air Liquide · Alcatel-Lucent · Alstom · Arcelor Mittal · AXA · BNP Paribas · Bouygues · Capgemini · Carrefour · Crédit Agricole · Dexia · EADS · EDF · Essilor · France Télécom · Gaz de France · Groupe Danone · L'Oréal · Lafarge · Lagardère · LVMH · Michelin · Pernod Ricard · PSA Peugeot Citroën · PPR · Renault · Saint-Gobain · Sanofi-Aventis · Schneider Electric · Société Générale · STMicroelectronics · SUEZ · Total · Unibail-Rodamco · Vallourec · Veolia Environnement · VINCI · Vivendi

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Sanofi-Aventis". A list of authors is available in Wikipedia.